Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate

Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate

US Patent 9708366 · Granted Jul 18, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic compounds and methods for their use in treating autism2021
Bicyclic compounds and methods for their use in treating autism2021
Bicyclic compounds and methods for their use in treating autism spectrum disorde2020
Bicyclic compounds and methods for their use in treating autism spectrum disorde2020
Systems and methods for improving central pharmacy-type dispensing operations2019
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Neuroprotective bicyclic compounds and methods for their use in treating autism 2018
Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid2015
Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid2015
Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals2015
Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals2014
2-adamantylethylamines and their use in the treatment of conditions generally as2004